Galimedix Therapeutics to Present at the BIO CEO & Investor Conference

World News: . []

KENSINGTON, Md. and SHORASHIM, Israel, Feb. 11, 2019 (GLOBE NEWSWIRE) -- Galimedix Therapeutics, which is developing new solutions for ophthalmic and neurodegenerative diseases, today announced Andrew Pearlman, Ph.D., Galimedix’s CEO, will present at the BIO CEO & Investor Conference in New York City.  Dr. Pearlman’s presentation will be on Tuesday, February 12, 2019 at 11:00 AM ET in the Chelsea Room.  The conference is being held at the New York Marriott Marquis in New York City.

Now in its 21st year, the BIO CEO & Investor Conference is one of the largest investor conferences focused on established and emerging publicly traded and select private biotech companies. Because its mission is to support industry-wide success, it presents a broad and unbiased view of investment opportunities.  Each year the BIO CEO & Investor Conference provides a neutral forum where institutional investors, industry analysts, and senior biotechnology executives have the opportunity to shape the future investment landscape of the biotechnology industry. The conference features issue-oriented plenary sessions, educational sessions focused on hot therapeutic areas and key business issues, company presentations, one-on-one meetings, and networking opportunities.

Galimedix has exclusive worldwide license from Tel Aviv University, following return of license by a German pharma (Merz) due to management change and strategic pivot away from neuroscience.  In the meantime, key members of the Merz Pharma team that developed the compound are now working with or for the company. The license also includes a next generation, potentially superior version, intended for oral delivery, with potential to treat retinal and other CNS diseases.    

Contact:Investors:Scott Gordon Core IR 631-703-4900

Media:Jules Abraham Core IR 917-885-7378

More news and information about Galimedix

Published By:

Globe Newswire: 13:30 GMT Monday 11th February 2019

Published: .

Search for other references to "galimedix" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us